LSTA Annual CFF
$385.00 K
+$609.00 K+271.88%
31 December 2023
Summary:
As of January 23, 2025, LSTA annual cash flow from financing activities is $385.00 thousand, with the most recent change of +$609.00 thousand (+271.88%) on December 31, 2023. During the last 3 years, it has fallen by -$18.20 million (-97.93%). LSTA annual CFF is now -99.55% below its all-time high of $85.28 million, reached on December 31, 2021.LSTA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LSTA Quarterly CFF
$0.00
-$32.00 K-100.00%
30 September 2024
Summary:
As of January 23, 2025, LSTA quarterly cash flow from financing activities is $0.00, with the most recent change of -$32.00 thousand (-100.00%) on September 30, 2024. Over the past year, it has dropped by -$24.00 thousand (-100.00%). LSTA quarterly CFF is now -100.00% below its all-time high of $85.30 million, reached on March 1, 2021.LSTA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LSTA TTM CFF
-$86.00 K
+$6000.00+6.52%
30 September 2024
Summary:
As of January 23, 2025, LSTA TTM cash flow from financing activities is -$86.00 thousand, with the most recent change of +$6000.00 (+6.52%) on September 30, 2024. Over the past year, it has dropped by -$471.00 thousand (-122.34%). LSTA TTM CFF is now -100.08% below its all-time high of $104.03 million, reached on March 1, 2021.LSTA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LSTA Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +271.9% | -100.0% | -122.3% |
| 3 y3 years | -97.9% | -100.0% | -122.3% |
| 5 y5 years | -53.3% | -100.0% | -122.3% |
LSTA Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.5% | +271.9% | -100.0% | +100.0% | -100.1% | +61.6% |
| 5 y | 5-year | -99.5% | +271.9% | -100.0% | +100.0% | -100.1% | +61.6% |
| alltime | all time | -99.5% | +141.3% | -100.0% | +100.0% | -100.1% | +99.0% |
Lisata Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(-100.0%) | -$86.00 K(-6.5%) |
| June 2024 | - | $32.00 K(-122.5%) | -$92.00 K(-128.0%) |
| Mar 2024 | - | -$142.00 K(-691.7%) | $328.00 K(-14.8%) |
| Dec 2023 | $385.00 K(-271.9%) | $24.00 K(-500.0%) | $385.00 K(+2.7%) |
| Sept 2023 | - | -$6000.00(-101.3%) | $375.00 K(+33.0%) |
| June 2023 | - | $452.00 K(-631.8%) | $282.00 K(-300.0%) |
| Mar 2023 | - | -$85.00 K(-707.1%) | -$141.00 K(-37.1%) |
| Dec 2022 | -$224.00 K(-100.3%) | $14.00 K(-114.1%) | -$224.00 K(+3.2%) |
| Sept 2022 | - | -$99.00 K(-441.4%) | -$217.00 K(+19.2%) |
| June 2022 | - | $29.00 K(-117.3%) | -$182.00 K(-3.7%) |
| Mar 2022 | - | -$168.00 K(-900.0%) | -$189.00 K(-100.2%) |
| Dec 2021 | $85.28 M(+359.0%) | - | - |
| Dec 2021 | - | $21.00 K(-132.8%) | $85.28 M(+0.0%) |
| Sept 2021 | - | -$64.00 K(-390.9%) | $85.27 M(-9.6%) |
| June 2021 | - | $22.00 K(-100.0%) | $94.36 M(-9.3%) |
| Mar 2021 | - | $85.30 M(>+9900.0%) | $104.03 M(+459.9%) |
| Dec 2020 | $18.58 M(+1470.6%) | $13.00 K(-99.9%) | $18.58 M(-1.4%) |
| Sept 2020 | - | $9.03 M(-6.7%) | $18.84 M(+92.1%) |
| June 2020 | - | $9.68 M(-6642.6%) | $9.81 M(+5845.5%) |
| Mar 2020 | - | -$148.00 K(-153.8%) | $165.00 K(-86.1%) |
| Dec 2019 | $1.18 M(+43.6%) | $275.00 K(>+9900.0%) | $1.18 M(+25.7%) |
| Sept 2019 | - | $0.00(-100.0%) | $941.00 K(-42.7%) |
| June 2019 | - | $38.00 K(-95.6%) | $1.64 M(-7.1%) |
| Mar 2019 | - | $870.00 K(+2536.4%) | $1.77 M(+114.3%) |
| Dec 2018 | $824.00 K(-188.4%) | $33.00 K(-95.3%) | $824.00 K(+34.3%) |
| Sept 2018 | - | $700.00 K(+329.4%) | $613.40 K(-70.4%) |
| June 2018 | - | $163.00 K(-326.4%) | $2.07 M(-124.2%) |
| Mar 2018 | - | -$72.00 K(-59.5%) | -$8.56 M(+818.0%) |
| Dec 2017 | -$932.00 K(-104.5%) | -$177.60 K(-108.2%) | -$932.00 K(+24.7%) |
| Sept 2017 | - | $2.16 M(-120.6%) | -$747.10 K(-117.2%) |
| June 2017 | - | -$10.46 M(-238.6%) | $4.33 M(-69.7%) |
| Mar 2017 | - | $7.55 M(>+9900.0%) | $14.27 M(-31.7%) |
| Dec 2016 | $20.90 M(-42.9%) | $7300.00(-99.9%) | $20.90 M(-1.3%) |
| Sept 2016 | - | $7.24 M(-1489.4%) | $21.18 M(+55.4%) |
| June 2016 | - | -$520.80 K(-103.7%) | $13.63 M(-68.5%) |
| Mar 2016 | - | $14.18 M(+4895.0%) | $43.29 M(+18.3%) |
| Dec 2015 | $36.60 M(+19.3%) | $283.90 K(-191.4%) | $36.60 M(-11.7%) |
| Sept 2015 | - | -$310.60 K(-101.1%) | $41.45 M(-24.3%) |
| June 2015 | - | $29.14 M(+288.9%) | $54.76 M(+79.9%) |
| Mar 2015 | - | $7.49 M(+46.2%) | $30.45 M(-0.7%) |
| Dec 2014 | $30.67 M(-50.7%) | $5.13 M(-60.6%) | $30.67 M(-52.0%) |
| Sept 2014 | - | $13.00 M(+169.3%) | $63.84 M(+5.8%) |
| June 2014 | - | $4.83 M(-37.5%) | $60.36 M(-10.2%) |
| Mar 2014 | - | $7.72 M(-79.8%) | $67.20 M(+8.1%) |
| Dec 2013 | $62.19 M(+611.4%) | $38.29 M(+302.4%) | $62.19 M(+180.0%) |
| Sept 2013 | - | $9.52 M(-18.5%) | $22.21 M(+54.3%) |
| June 2013 | - | $11.67 M(+331.5%) | $14.39 M(+237.8%) |
| Mar 2013 | - | $2.71 M(-261.0%) | $4.26 M(-51.2%) |
| Dec 2012 | $8.74 M(-56.4%) | -$1.68 M(-199.1%) | $8.74 M(-37.4%) |
| Sept 2012 | - | $1.70 M(+10.0%) | $13.98 M(-29.9%) |
| June 2012 | - | $1.54 M(-78.5%) | $19.95 M(-1.1%) |
| Mar 2012 | - | $7.19 M(+102.2%) | $20.17 M(+0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | $20.07 M(-40.7%) | $3.55 M(-53.7%) | $20.07 M(-49.0%) |
| Sept 2011 | - | $7.67 M(+333.4%) | $39.38 M(+43.2%) |
| June 2011 | - | $1.77 M(-75.0%) | $27.50 M(-6.7%) |
| Mar 2011 | - | $7.08 M(-69.0%) | $29.48 M(-12.9%) |
| Dec 2010 | $33.86 M(+90.4%) | $22.86 M(-643.4%) | $33.86 M(+160.9%) |
| Sept 2010 | - | -$4.21 M(-212.5%) | $12.98 M(-26.5%) |
| June 2010 | - | $3.74 M(-67.4%) | $17.66 M(-37.0%) |
| Mar 2010 | - | $11.46 M(+478.0%) | $28.02 M(+57.6%) |
| Dec 2009 | $17.78 M(+520.0%) | $1.98 M(+312.8%) | $17.78 M(+7.6%) |
| Sept 2009 | - | $480.30 K(-96.6%) | $16.53 M(-4.2%) |
| June 2009 | - | $14.10 M(+1055.1%) | $17.26 M(+329.5%) |
| Mar 2009 | - | $1.22 M(+66.6%) | $4.02 M(+40.1%) |
| Dec 2008 | $2.87 M(-63.4%) | $732.80 K(-39.5%) | $2.87 M(+33.1%) |
| Sept 2008 | - | $1.21 M(+41.4%) | $2.16 M(-66.7%) |
| June 2008 | - | $855.70 K(+1127.7%) | $6.48 M(+16.1%) |
| Mar 2008 | - | $69.70 K(+257.4%) | $5.58 M(-28.8%) |
| Dec 2007 | $7.85 M(+116.2%) | $19.50 K(-99.6%) | $7.85 M(+1.3%) |
| Sept 2007 | - | $5.54 M(<-9900.0%) | $7.74 M(+108.5%) |
| June 2007 | - | -$41.50 K(-101.8%) | $3.71 M(-33.6%) |
| Mar 2007 | - | $2.33 M(-2924.7%) | $5.60 M(+54.1%) |
| Dec 2006 | $3.63 M(+180.3%) | -$82.60 K(-105.5%) | $3.63 M(-20.2%) |
| Sept 2006 | - | $1.51 M(-18.1%) | $4.55 M(+42.2%) |
| June 2006 | - | $1.84 M(+399.9%) | $3.20 M(+101.0%) |
| Mar 2006 | - | $367.90 K(-55.9%) | $1.59 M(+22.8%) |
| Dec 2005 | $1.29 M(+1.2%) | $835.00 K(+438.7%) | $1.29 M(+254.4%) |
| Sept 2005 | - | $155.00 K(-33.5%) | $365.40 K(-64.4%) |
| June 2005 | - | $233.00 K(+223.6%) | $1.03 M(-10.2%) |
| Mar 2005 | - | $72.00 K(-176.1%) | $1.14 M(-10.8%) |
| Dec 2004 | $1.28 M(+249.5%) | -$94.60 K(-111.6%) | $1.28 M(-16.8%) |
| Sept 2004 | - | $815.30 K(+133.5%) | $1.54 M(+108.3%) |
| June 2004 | - | $349.20 K(+66.3%) | $738.60 K(+41.8%) |
| Mar 2004 | - | $210.00 K(+28.1%) | $520.80 K(+42.3%) |
| Dec 2003 | $366.20 K(+74.5%) | $163.90 K(+957.4%) | $366.10 K(+85.9%) |
| Sept 2003 | - | $15.50 K(-88.2%) | $196.90 K(-39.6%) |
| June 2003 | - | $131.40 K(+137.6%) | $326.20 K(+20.5%) |
| Mar 2003 | - | $55.30 K(-1143.4%) | $270.70 K(+28.9%) |
| Dec 2002 | $209.90 K(-997.0%) | -$5300.00(-103.7%) | $210.00 K(+1.2%) |
| Sept 2002 | - | $144.80 K(+90.8%) | $207.50 K(+260.9%) |
| June 2002 | - | $75.90 K(-1505.6%) | $57.50 K(-341.6%) |
| Mar 2002 | - | -$5400.00(-30.8%) | -$23.80 K(+1.7%) |
| Dec 2001 | -$23.40 K(-102.0%) | -$7800.00(+50.0%) | -$23.40 K(+10.9%) |
| Sept 2001 | - | -$5200.00(-3.7%) | -$21.10 K(-1.4%) |
| June 2001 | - | -$5400.00(+8.0%) | -$21.40 K(-86.4%) |
| Mar 2001 | - | -$5000.00(-9.1%) | -$156.90 K(-113.3%) |
| Dec 2000 | $1.18 M(-72.7%) | -$5500.00(0.0%) | $1.18 M(-0.5%) |
| Sept 2000 | - | -$5500.00(-96.1%) | $1.19 M(-0.5%) |
| June 2000 | - | -$140.90 K(-110.6%) | $1.19 M(-10.6%) |
| Mar 2000 | - | $1.34 M | $1.34 M |
| Dec 1999 | $4.34 M(+5884.6%) | - | - |
| Dec 1998 | $72.50 K(-94.8%) | - | - |
| Mar 1998 | $1.39 M(+336.5%) | - | - |
| Mar 1997 | $317.40 K(-62.4%) | - | - |
| Mar 1996 | $844.30 K | - | - |
FAQ
- What is Lisata Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Lisata Therapeutics?
- What is Lisata Therapeutics annual CFF year-on-year change?
- What is Lisata Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Lisata Therapeutics?
- What is Lisata Therapeutics quarterly CFF year-on-year change?
- What is Lisata Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Lisata Therapeutics?
- What is Lisata Therapeutics TTM CFF year-on-year change?
What is Lisata Therapeutics annual cash flow from financing activities?
The current annual CFF of LSTA is $385.00 K
What is the all time high annual CFF for Lisata Therapeutics?
Lisata Therapeutics all-time high annual cash flow from financing activities is $85.28 M
What is Lisata Therapeutics annual CFF year-on-year change?
Over the past year, LSTA annual cash flow from financing activities has changed by +$609.00 K (+271.88%)
What is Lisata Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of LSTA is $0.00
What is the all time high quarterly CFF for Lisata Therapeutics?
Lisata Therapeutics all-time high quarterly cash flow from financing activities is $85.30 M
What is Lisata Therapeutics quarterly CFF year-on-year change?
Over the past year, LSTA quarterly cash flow from financing activities has changed by -$24.00 K (-100.00%)
What is Lisata Therapeutics TTM cash flow from financing activities?
The current TTM CFF of LSTA is -$86.00 K
What is the all time high TTM CFF for Lisata Therapeutics?
Lisata Therapeutics all-time high TTM cash flow from financing activities is $104.03 M
What is Lisata Therapeutics TTM CFF year-on-year change?
Over the past year, LSTA TTM cash flow from financing activities has changed by -$471.00 K (-122.34%)